Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0000947871-24-000703

Director sold 250,000 shares at $44.01 ($11,002,500)

From the SEC's structured data for this filing

Trades in this filing

GORDON CARL L · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-13 Sale : show line 1 in the form −220,600 $44.01 $9,708,606 899,212 I
2024-08-13 Sale : show line 2 in the form −29,400 $44.01 $1,293,894 119,522 I
Open-market sales · 250,000 sh · avg $44.01 · $11,002,500
Loading xslF345X05/ownership.xml…